🏛️ Verified NIH Record • Updated 2026-05-29

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction (NCT07135596)

Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation

🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Tela Bio Inc

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.

Who can join: Review the eligibility criteria below.

Location: Qualmedica Research — Bowling Green, Kentucky

Age range: 22 Years to 75 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

  • Qualmedica Research — Bowling Green, Kentucky
  • WakeMed — Raleigh, North Carolina

📞 Contact the Study Coordinator

Phone: (484) 320-2930

Email: telaclinicalresearch@telabio.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗